ArticleNaunyn-Schmiedeberg's archives of pharmacology2025
The antihypertensive effect of the coadministration of exercise and eugenol in deoxycorticosterone acetate-induced hypertension in rats.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Swimming exercise improves vascular function and mitigates cardiac apoptotic response via Bcl-2 and Caspase-3 pathway in streptozotocin-induced diabetic rats: in vivo and in silico molecular docking study.European journal of medical research · 2025Article
- Cardiovascular and renal effects of 5-aminoimidazole-4-carboxyribonucleoside (AICAR) in the deoxycorticosterone acetate (DOCA)-salt rat model of hypertension.Life sciences · 2025Article
Corrections and comments
- Retraction · 2025-10-20Duplication of/in Image · Euphemisms for Duplication · Investigation by Journal/Publisher · Objections by Author(s) · Unreliable Results and/or Conclusions ·
- Retracted
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension (HTN) is a significant health issue with high morbidity, especially in the cardiovascular system, leading to mortality. HTN could be treated with exercise (Ex) and eugenol due to their antioxidant, anti-inflammatory, and antiapoptotic activities. 48 male Wistar rats (n = 8) were assigned to normal, deoxycorticosterone acetate (DOCA), losartan + DOCA, Ex + DOCA, eugenol + DOCA, and Ex + eugenol + DOCA groups. Blood pressure (BP), echocardiography, serum electrolytes, lipid profile, total antioxidant capacity (TAC), interleukin- 6 (IL- 6), endocan, endothelin- 1 (ET- 1), transforming growth factor-β1 (TGF-β1), plasma renin activity (PRA), and serum aldosterone were measured. PCR analyzed p38 mitogen-activated protein kinase (p38MAPK), c-Jun N-terminal kinases (JNK), and collagen 1 expression. Histopathology was used to evaluate heart and kidney tissues. Cardiac apoptosis was assessed using TUNEL staining. Losartan, aerobic Ex (30 min/day, 5 days/week), combined eugenol and Ex, and eugenol therapy mitigated systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), heart rate (HR), left ventricular end-diastolic volume (LVEDV), serum sodium, IL- 6, endocan, ET- 1, TGF-β1, PRA, and serum aldosterone. These therapies attenuated histopathological changes, cardiac apoptosis, p38MAPK, JNK, and collagen 1. Conversely, ejection fraction (EF), serum potassium, and TAC levels were elevated compared to the DOCA group. Ex and eugenol monotherapy ameliorated DOCA-induced HTN in rats. Ex + eugenol combination showed equal efficacy to losartan in ameliorating DOCA-induced HTN, with better efficacy than Ex or eugenol alone. The combination's antihypertensive effect may result from the synergistic/additive antioxidant, anti-inflammatory, and antiapoptotic effects of either therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.